Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes

Journal of Experimental Medicine

Volumn 187, Issue 5, 1998, Pages 685-691

  Ciupitu, Anne Marie T ^a   Petersson, Max ^a   O'Donnell, Carey L ^b   Williams, Kevin ^c   Jindal, Satish ^d   Kiessling, Rolf ^a,e   Welsh, Raymond M ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c BIOGEN   (United States)

^d NeoGenesis Pharmaceuticals Inc   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEAT SHOCK PROTEIN 70; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; HSP70 HEAT-SHOCK PROTEINS; IMMUNITY, CELLULAR; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MICE; MICE, INBRED C57BL; PEPTIDES; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, CYTOTOXIC; VIRAL VACCINES;

EID: 0032473485     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.5.685     Document Type: Article

References (29)

1. Gething, M.-J., and J Sambrook. 1992. Protein folding in the cell. Nature. 355:33-45.
2. Hartl, F.-U., R. Hlodan, and T. Langer. 1994. Molecular chaperones in protein folding: the art of avoiding sticky situations. TIBS (Trends Biochem. Sci.). 19:20-25.
3. Blond-Elguindi, S., S.E. Cwirla, W.J. Dower, R.J. Lipshutz, S.R. Sprang, J.F. Sambrook, and M.J.H. Gething. 1993. Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell. 75:717-728.
4. Fourie, A.M., J.F. Sambrook, and M.J.H. Gething. 1994. Common and divergent peptide binding specificities of hsp70 molecular chaperones. J. Biol. Chem. 269:30470-30478.
5. Craig, E.A., J.S. Weissman, and A.L. Horwich. 1994. Heat shock proteins and molecular chaperones: mediators of protein conformation and turnover in the cell. Cell. 78:365-372.
6. Suzuke, K., and R.A. Young. 1996. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. J. Immunol. 156:873-879.
7. Román, E., and C. Moreno. 1996. Synthetic peptides noncovalently bound to bacterial hsp70 elicit peptide-specific T-cell responses in vivo. Immunology. 88:487-492.
8. Udono, H., and P.K. Srivastava. 1993. Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med. 178:1391-1396.
9. Udono, H., and P.K. Srivastava. 1994. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70. J. Immunol. 152:5398-5403.
10. Suto, R., and P.K. Srivastava. 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science. 269:1585-1588.
11. Zinkernagel, R.M., D. Moskophidis, T. Kündig, S. Oehen, H. Pircher, and H. Hengartner. 1993. Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. Immunol. Rev. 131:199-223.
12. Lewicki, H., A. Tishon, P. Borrow, C.F. Evans, J.E. Gairin, K.M. Hahn, D.A. Jewell, I.A. Wilson, and M.B.A. Oldstone. 1995. CTL escape viral variants. I. Generation and molecular characterization. Virology. 210:29-40.
13. Lewicki, H., M.G. von Herrath, C.F. Evans, J.L. Whitton, and M.B.A. Oldstone. 1995. CTL escape viral variants. II. Biologic activity in vivo. Virology. 211:443-450.
14. Welsh, R.M., P.W. Lampert, P.A. Burner, and M.B.A. Oldstone. 1976. Antibody-complement interactions with purified lymphocytic choriomeningitis virus. Virology. 73:59-71.
15. Kärre, K., H.G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defense strategies. Nature. 319: 675-678.
16. Selin, L.K., K. Vergilis, R.M. Welsh, and S.R. Nahill. 1996. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infection. J. Exp. Med. 183:2489-2499.
17. Jindal, S., S. Rosenberg, P. Murray, R.A. Young, and K.P. Williams. 1995. Human stress protein hsp70: overexpression in E. coli, purification and characterization. Bio/technology. 13:1105-1109.
18. Palleros, D.R., W.J. Welch, and A.L. Fink. 1991. Interaction of hsp70 with unfolded proteins: effects of temperature and nucleotides on the kinetics of binding. Proc. Natl. Acad. Sci. USA. 88:5719-5723.
19. Flynn, G.C., T.G. Chappell, and J.E. Rothman. 1989. Peptide binding and release by proteins implicated as catalysts of protein assembly. Science. 245:385-390.
20. Welsh, R.M. 1978. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J. Exp. Med. 148:163.
21. Battery, M., S. Oehen, M. Schulz, H. Hengartner, and R.M. Zinkernagel. 1992. Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology. J. Virol. 66:1199-1201.
22. Srivastava, P.K., H. Udono, N.E. Blanchere, and Z. Li. 1994. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics. 39:93-98.
23. Blachere, N.E., H. Udono, S. Janetzki, Z. Li, M. Heike, and P.K. Srivastava. 1993. Heat shock protein vaccines against cancer. J. Immunother. 14:352-356.
24. Heikema, A., E. Agsteribbe, J. Wilschut, and A. Huckriede. 1997. Generation of heat shock protein-based vaccines by intracellular loading of gp96 with antigenic peptides. Immunol. Lett. 57:69-74.
25. Blachere, N.E., Z. Li, R.Y. Chandawarkar, R. Suto, N.S. Jaikaria, S. Basn, H. Udono, P.K. Srivastava. 1997. Heat shock protein-peptide complexes, reconstituted in vivo, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186:1315-1322.
26. Bloom, M.B., D. Perrylalley, P.F. Robbins, Y. Li, M. Elgamil, S.A. Rosenberg, and J.C. Yang. 1997. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J. Exp. Med. 185:453-459.
27. Boon, T. 1993. Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy. Int. J. Cancer. 54:177-180.
28. Toes, R.E., R.J. Blom, R. Offringa, W.M. Kast, and C.J. Melief. 1996. Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors. J. Immunol. 156:3911-3918.
29. Diris, M.L., J.R. Gralow, H. Bernhard, S.L. Hand, W.D. Rubin, and M.A. Cheever. 1996. Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, an oncogenic self-protein. J. Immunol. 156:3151-3158.